Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats

Neuropharmacology

Volumn 50, Issue 7, 2006, Pages 824-833

  Kim, Sung Jin ^a   Park, Sang Ha ^a   Choi, Song hyen ^a   Moon, Bo Hyun ^a   Lee, Kuem Ju ^a   Kang, Seung Woo ^a   Lee, Min Soo ^a   Choi, Sang Hyun ^a   Chun, Boe Gwun ^a   Shin, Kyung Ho ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Amygdala; Anxiety; Bed nucleus of the stria terminalis; Corticotropin releasing factor; Depression; Stress; Tianeptine

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; SODIUM CHLORIDE; TIANEPTINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FLUID INTAKE; FOOD INTAKE; MALE; MENTAL STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRIA TERMINALIS;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION REGULATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STRESS; THIAZEPINES;

EID: 33646679190     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.12.003     Document Type: Article

References (48)

1. Albeck D.S., McKittrick C.R., Blanchard D.C., Blanchard R.J., Nikulina J., McEwen B.S., and Sakai R.R. Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain. J. Neurosci. 17 (1997) 4895-4903
2. Alheid G.F., de Lomos J.S., and Beltramino C.A. Amygdala and extended amygdala. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press, San Diego 495-578
3. Alonso G., Szafarczyk A., Balmefrezol M., and Assenmacher I. Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats. Brain Res. 397 (1986) 297-307
4. Amir S., Lamont E.W., Robinson B., and Stewart J. A circadian rhythm in the expression of PERIOD2 protein reveals a novel SCN-controlled oscillator in the oval nucleus of the bed nucleus of the stria terminalis. J. Neurosci. 24 (2004) 781-790
5. Armario A., Valles A., Dal-Zotto S., Marquez C., and Belda X. A single exposure to severe stressors causes long-term desensitisation of the physiological response to the homotypic stressor. Stress 7 (2004) 157-172
6. Aston-Jones G., Delfs J.M., Druhan J., and Zhu Y. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann. N.Y. Acad. Sci. 877 (1999) 486-498
7. Banki C.M., Bissette G., Arato M., O'Connor L., and Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am. J. Psychiatry 144 (1987) 873-877
8. Burghardt N.S., Sullivan G.M., McEwen B.S., Gorman J.M., and LeDoux J.E. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol. Psychiatry 55 (2004) 1171-1178
9. Castanon N., Konsman J.P., Medina C., Chauvet N., and Dantzer R. Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation. Psychoneuroendocrinology 28 (2003) 19-34
10. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., and Nemeroff C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 6 (1986) 2908-2914
11. Ciccocioppo R., Fedeli A., Economidou D., Policani F., Weiss F., and Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J. Neurosci. 23 (2003) 9445-9451
12. Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., and Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl Acad. Sci. U.S.A. 98 (2001) 12796-12801
13. D'Aquila P.S., Brain P., and Willner P. Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol. Behav. 56 (1994) 861-867
14. Davis M., Walker D.L., and Lee Y. Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philos. Trans. R. Soc. Lond. B Biol. Sci. 352 (1997) 1675-1687
15. De Bellis M.D., Gold P.W., Geracioti Jr. T.D., Listwak S.J., and Kling M.A. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am. J. Psychiatry 150 (1993) 656-657
16. Delbende C., Tranchand Bunel D., Tarozzo G., Grino M., Oliver C., Mocaer E., and Vaudry H. Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo-pituitary-adrenal axis. Eur. J. Pharmacol. 251 (1994) 245-251
17. Dong H.W., Petrovich G.D., Watts A.G., and Swanson L.W. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J. Comp. Neurol. 436 (2001) 430-455
18. Duncko R., Kiss A., Skultetyova I., Rusnak M., and Jezova D. Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosine hydroxylase mRNA levels decrease in both sexes. Psychoneuroendocrinology 26 (2001) 77-89
19. Egli R.E., and Winder D.G. Dorsal and ventral distribution of excitable and synaptic properties of neurons of the bed nucleus of the stria terminalis. J. Neurophysiol. 90 (2003) 405-414
20. Imaki T., Nahan J.L., Rivier C., Sawchenko P.E., and Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 11 (1991) 585-599
21. Itoi K., Suda T., Tozawa F., Dobashi I., Ohmori N., Sakai Y., Abe K., and Demura H. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology 135 (1994) 2177-2182
22. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry 46 (1999) 1167-1180
23. Lee Y., and Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J. Neurosci. 17 (1997) 6434-6446
24. Ma X.M., and Lightman S.L. The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats. J. Physiol. 510 Pt 2 (1998) 605-614
25. Macey D.J., Smith H.R., Nader M.A., and Porrino L.J. Chronic cocaine self-administration upregulates the norepinephrine transporter and alters functional activity in the bed nucleus of the stria terminalis of the rhesus monkey. J. Neurosci. 23 (2003) 12-16
26. Makino S., Gold P.W., and Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res. 657 (1994) 141-149
27. Makino S., Shibasaki T., Yamauchi N., Nishioka T., Mimoto T., Wakabayashi I., Gold P.W., and Hashimoto K. Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat. Brain Res. 850 (1999) 136-143
28. Marti O., Harbuz M.S., Andres R., Lightman S.L., and Armario A. Activation of the hypothalamic-pituitary axis in adrenalectomised rats: potentiation by chronic stress. Brain Res. 821 (1999) 1-7
29. Mennini T., Mocaer E., and Garattini S. Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 336 (1987) 478-482
30. Moreau J.L., Jenck F., Martin J.R., Mortas P., and Haefely W.E. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur. Neuropsychopharmacol. 2 (1992) 43-49
31. Morin S.M., Ling N., Liu X.J., Kahl S.D., and Gehlert D.R. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 92 (1999) 281-291
32. Nemeroff C.B., Bissette G., Akil H., and Fink M. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin. Br. J. Psychiatry 158 (1991) 59-63
33. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., and Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226 (1984) 1342-1344
34. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
35. Pacak K., McCarty R., Palkovits M., Kopin I.J., and Goldstein D.S. Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats. Brain Res. 688 (1995) 242-246
36. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fourth ed. (1998), Academic Press, Orlando
37. Pillai, A.G., Munoz, C., Chattarji, S., 2004. The antidepressant tianeptine prevents the dendritic hypertrophy in the amygdala and increase in anxiety induced by chronic stress in the rat. Abstract # 762.1, Society for Neuroscience.
38. Quirarte G.L., Galvez R., Roozendaal B., and McGaugh J.L. Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs. Brain Res. 808 (1998) 134-140
39. Sacchetti G., Bonini I., Waeterloos G.C., and Samanin R. Tianeptine raises dopamine and blocks stress-induced noradrenaline release in the rat frontal cortex. Eur. J. Pharmacol. 236 (1993) 171-175
40. Sakanaka M., Shibasaki T., and Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 382 (1986) 213-238
41. Spencer S.J., Buller K.M., and Day T.A. Medial prefrontal cortex control of the paraventricular hypothalamic nucleus response to psychological stress: possible role of the bed nucleus of the stria terminalis. J. Comp. Neurol. 481 (2005) 363-376
42. Stout S.C., Mortas P., Owens M.J., Nemeroff C.B., and Moreau J. Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. Eur. J. Pharmacol. 401 (2000) 39-46
43. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
44. Vyas A., Bernal S., and Chattarji S. Effects of chronic stress on dendritic arborization in the central and extended amygdala. Brain Res. 965 (2003) 290-294
45. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur. J. Pharmacol. 463 (2003) 199-216
46. Watanabe Y., Gould E., Daniels D.C., Cameron H., and McEwen B.S. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur. J. Pharmacol. 222 (1992) 157-162
47. Wilde M.I., and Benfield P. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 49 (1995) 411-439
48. Willner P., Moreau J.L., Nielsen C.K., Papp M., and Sluzewska A. Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiol. Behav. 60 (1996) 129-134